adipocyte P2 monoclonal antibodies (UCB)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameadipocyte P2 monoclonal antibodies (UCB)

Drug Alias NameCA-33

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionFatty acid-binding protein, adipocyte inhibitors

TargetsFatty acid-binding protein, adipocyte

Therapy Area/IndicationsObesityDiabetes Mellitus

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelgium

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesUcb Sa

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesUcb Sa

Active IndicationsN/A

Inactive IndicationsObesityDiabetes Mellitus

ATC CodeN/A